Initiatives and programs
Signed by all Australian governments, the 2020–25 Addendum to National Health Reform Agreement (NHRA) aims to improve health outcomes for all Australians and ensure our health system is sustainable.
We are establishing an Australian Centre for Disease Control (CDC) to improve Australia's ongoing response to current and emerging public health emergencies. Learn more about the Australian CDC.
The Australian Thalidomide Survivors Support Program provides support to Australian thalidomide survivors. Find out about the program, including who is eligible and what support is available.
The Cardiovascular Health Mission is investing $220 million. It brings together researchers, health professionals, industry and patients to make transformative improvements in heart and vascular health and stroke for all Australians.
The Clinical Trials Activity initiative will provide $750 million over 10 years from 2022-23. It will help Australian researchers and patients test new treatments through national and international clinical trials.
The Inborn Errors of Metabolism (IEM) program helps people and families who have problems with breaking down protein in their food. They need a special diet, and the IEM program helps them pay for their specialised food.
The Australian Government is investing in a multi-year Intergenerational Health and Mental Health Study (IHMHS). The IHMHS will provide the most complete picture ever collected of Australia's physical and mental health.
The National Diabetes Services Scheme (NDSS) helps people with diabetes to understand and manage their life with diabetes. It also provides timely, reliable and affordable access to diabetes support services and products.
The NEBDS helps eligible people with epidermolysis bullosa access dressings, bandages and ancillary products at a reduced cost. It also ensures a consistent level of care across Australia. The scheme is currently administered by Independence Australia on behalf of the Australian Government.
Healthcare providers offer bloodspot screening for all babies born in Australia. This simple test identifies babies at risk of becoming seriously ill from a rare condition. Screening aims to improve the health of these babies by allowing early intervention.